Pfizer Inc (NYSE:PFE)

43.80
Delayed Data
As of Dec 14
 -0.77 / -1.73%
Today’s Change
33.20
Today|||52-Week Range
46.47
+20.93%
Year-to-Date
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
Dec 14 / Zacks.com - Paid Partner Content
Stocks Close Marginally Higher Monday
Dec 10 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus
Dec 14 / Zacks.com - Paid Partner Content
Conatus' Emricasan Misses Primary Endpoint in Mid-Stage Study
Dec 06 / Zacks.com - Paid Partner Content
Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Strong ETF Right Now?
Dec 13 / Zacks.com - Paid Partner Content
Exelixis Initiates Pivotal Liver Cancer Study on Cabometyx
Dec 06 / Zacks.com - Paid Partner Content
Pfizer's (PFE) Shares Drop on Rating Downgrade by JP Morgan
Dec 12 / Zacks.com - Paid Partner Content
Pfizer (PFE) Stock Moves -1.78%: What You Should Know
Dec 04 / Zacks.com - Paid Partner Content
Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know
Dec 10 / Zacks.com - Paid Partner Content
AbbVie Settles With Pfizer for Humira Biosimilar in U.S.
Dec 03 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close44.57
Today’s open44.08
Day’s range43.43 - 44.12
Volume31,333,031
Average volume (3 months)21,998,899
Market cap$250.0B
Data as of 4:03pm ET, 12/14/2018

Growth & Valuation

Earnings growth (last year)+202.42%
Earnings growth (this year)+13.46%
Earnings growth (next 5 years)+7.40%
Revenue growth (last year)-0.53%
P/E ratio11.1
Price/Sales4.18
Price/Book3.61

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-1.01-1.14%
MRKMerck-1.98-2.52%
ABBVAbbVie-2.10-2.39%
ABTAbbott Laboratories-1.42-1.97%
Data as of 4:02pm ET, 12/14/2018

Financials

Next reporting dateJanuary 29, 2019
EPS forecast (this quarter)$0.65
Annual revenue (last year)$52.5B
Annual profit (last year)$21.3B
Net profit margin40.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Operating Officer &
Director
Albert Bourla
Corporate headquarters
New York, New York

Forecasts